Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE4
40 participants
INTERVENTIONAL
2025-01-24
2026-03-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Corticosteroid vs Platelet-Rich Plasma Intra-articular Injections in the Treatment of Knee Osteoarthritis.
NCT06032039
The Efficacy of Intra-articular Triamcinolone Acetonide 5mg vs. 10 mg vs. 40 mg in Patients With Knee Osteoarthritis
NCT05806021
Do Knee Injections Offer Benefit With Knee Arthritis Pain
NCT04017949
Corticosteroid/Ropivacaine Versus Corticosteroid/Saline Injections for Knee Osteoarthritis
NCT02576249
Is Botox Effective in Relieving Pain From Knee Osteoarthritis?
NCT00279903
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard Dose Group
Patients with knee osteoarthritis who are interested in knee intra-articular corticosteroid injections and meet the inclusion criteria.
Triamcinolone Acetonide Standard Dose
Subjects will receive the standard of care dose of 40mg triamcinolone acetonide
Total injection volume of 5ml, consisting of:
* 1ml triamcinolone acetonide (40mg)
* 4ml lidocaine (40mg)
Lower Dose Group
Patients with knee osteoarthritis who are interested in knee intra-articular corticosteroid injections and meet the inclusion criteria.
Triamcinolone Acetonide Low Dose
Subjects will receive a reduced dose of 20mg of triamcinolone acetonide.
Total injection volume of 5ml, consisting of:
* 0.5ml triamcinolone acetonide (20mg)
* 4.5ml lidocaine (45mg)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Triamcinolone Acetonide Low Dose
Subjects will receive a reduced dose of 20mg of triamcinolone acetonide.
Total injection volume of 5ml, consisting of:
* 0.5ml triamcinolone acetonide (20mg)
* 4.5ml lidocaine (45mg)
Triamcinolone Acetonide Standard Dose
Subjects will receive the standard of care dose of 40mg triamcinolone acetonide
Total injection volume of 5ml, consisting of:
* 1ml triamcinolone acetonide (40mg)
* 4ml lidocaine (40mg)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Uncontrolled diabetics with a hemoglobin A1c \> 8%
* No other treatment within the time frame of the study.
* Patients that are undergoing physical therapy at the time of the study.
55 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jeff P. Nadwodny
Assistant Professor of Family Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jeffrey P Nadwodny, DO
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic in Florida
Jacksonville, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Related Links
Access external resources that provide additional context or updates about the study.
Mayo Clinic Clinical Trials
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
24-005200
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.